Environment
day one project

Repurposing Generic Drugs to Combat Cancer

04.06.21 | 1 min read | Text by Laura Kleiman & Shruthi Bhimaraju

Summary

Cancer patients urgently need more effective treatments that are accessible to everyone. This year alone, an estimated 1.9 million people in the United States will receive new cancer diagnoses, and cancer will kill more than 600,000 Americans. Yet there are no targeted therapeutics for many cancers, and the treatments that do exist can be prohibitively scarce or expensive.

Repurposing existing drugs, especially off-patent generics, is the fastest way to develop new treatments. Hundreds of non-cancer generic drugs have already been tested by researchers and physicians in preclinical and clinical studies for cancer, some up to Phase II trials, and show intriguing promise. But due to a market failure, there is a lack of funding for clinical trials that evaluate generic drugs. This means that there isn’t conclusive evidence of the efficacy and safety of repurposed generics for treating cancer, and so cancer patients who desperately need more (and more affordable) treatment options are unable to realize the benefits that existing generics might offer.

To quickly and affordably improve the lives of cancer patients, the Biden-Harris Administration should create the Repurposing Generics Grant Program through the National Cancer Institute. This program would fund definitive clinical trials evaluating repurposed generic drugs for cancer. A key first step would be for President Biden to include this program in his FY2022 budget proposal. Congress could then authorize the program and related appropriations totaling $100 million over 5 years.

publications
See all publications
Environment
Article
How Methane Emissions Events Impact Air Quality and Put Human Health at Risk

99% of the natural gas sampled near the point of extraction across the country contains hazardous air pollutants harmful to health.

07.30.26 | 11 min read
read more
Environment
Policy Statement
Position on the Wildfire Emissions Prevention Act of 2026 (WEPA)

The Federation of American Scientists supports the Wildfire Emissions Prevention Act of 2026 (WEPA). The Act would amend Section 319(b) of the Clean Air Act so that it addresses prescribed burns as a standalone activity. If passed, this bill would support wildfire resilience by reducing administrative barriers to getting needed prescribed burns on the ground.  […]

07.27.26 | 2 min read
read more
Environment
Press release
Endorsement of the National Coordination on Adaptation and Resilience for Security (NCARS) Act of 2026

The NCARS Act would amend the National Security Act of 1947 to establish a durable, coordinated federal approach to national resilience.

07.17.26 | 2 min read
read more
Environment
Press release
Amid Sweltering Weather, the Federation of American Scientists Releases Expert-Sourced “State and Local Heat Policy Agenda”

Nearly 150 organizations and government officials have endorsed the call to action and solutions for extreme heat, now public at HeatAgenda.US Washington, D.C. – July 7, 2026 – As millions of Americans continue to struggle to stay cool following one of the hottest Independence Day holidays on record, the Federation of American Scientists (FAS), one […]

07.07.26 | 3 min read
read more